The other factors established in clinical routine, including tumour stage, lymph node status, histological grading as well as the status of the hormone receptors and HER2, show significant correlations in overall and/or recurrence-free survival analysis, underlining the fact that the set of breast carcinomas used in our investigation was not biased (Table 3). The gene discussed is NR4A1; the disease is breast carcinoma.